Is using a consolidation tumor ratio 0.5 as criterion feasible in daily practice? Evaluation of interobserver measurement variability of consolidation tumor ratio of lung cancer less than 3 cm in size.
Sachie KoikeKimihiro ShimizuShogo IdeShuji MishimaShunichiro MatsuokaTetsu TakedaKentaro MiuraTakashi EguchiKazutoshi HamanakaTaisuke ArakiKei SoneharaKeisuke TodorokiFumihito IchinoheSatoshi KawakamiMasayoshi KoinumaPublished in: Thoracic cancer (2022)
CTR 0.5 is a clinically relevant and helpful cutoff for treatment decision-making in patients with early-stage lung cancer based on high interobserver agreement and good prognostic stratification.